{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:05Z","timestamp":1790710145826,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Background: ANCA-associated vasculitis (AAV) are small vessel vasculitis distinguished between microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). The former may have interstitial lung disease (ILD) associated with high morbidity and mortality. Here, Krebs von den Lungen-6 (KL-6), a marker of fibrotic ILD, was assessed for distinguishing AAV patients with ILD from those without ILD, and whether its changes over time are correlated with disease activity. Materials and Methods: Thirteen AAV patients (eight females, mean age 61 \u00b1 14.8 years) were enrolled: six MPA and six GPA. Serum samples were assayed for KL-6 concentrations (Fujirebio Europe, Belgium). To investigate potential binary classifiers for diagnosis of AAV-ILD, we constructed a regression decision tree model. Results: Higher serum KL-6 were in AAV-ILD compared with those without ILD (972.8 \u00b1 398.5 vs 305.4 \u00b1 93.9, p = 0.0040). Area under the receiver operating characteristics curve showed 100% of the diagnostic performance of KL-6 for identifying the ILD involvement (accuracy 91.7%) and the best cutoff value of 368 U\/mL (sensitivity 100% and specificity 87.5%). The decision tree model showed a 33% improvement in class purity using a cut-off value of 513 U\/mL to distinguish AAV patients with and without ILD. Stratifying AAV patients as MPA and GPA with and without ILD considering T0 and T1 KL-6, the model obtained an improvement of 40% for classifying GPA non-ILD with a T0 serum KL-6 cut-off value of 513 U\/mL and a T1 KL-6 cut-off of 301 U\/mL. A direct correlation was found between serum T0 KL-6 and T0 BVAS (r = 0.578, p = 0.044). Conclusion: Our multicenter study demonstrated KL-6 as a reliable, non-invasive, and easy-to-perform marker of ILD in AAV patients and its helpfulness for disease activity assessment. Changes in serum concentrations of KL-6 over time could be useful for monitoring AAV patients. Further study of KL-6 as a marker of response to therapy during long-term follow-up would also be worthwhile.<\/jats:p>","DOI":"10.3390\/biology11010094","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"94","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3974-6606","authenticated-orcid":false,"given":"Edoardo","family":"Conticini","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, Surgery & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5722","authenticated-orcid":false,"given":"Miriana","family":"d\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-3223","authenticated-orcid":false,"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-3595","authenticated-orcid":false,"given":"Diego","family":"Castillo","sequence":"additional","affiliation":[{"name":"Respiratory Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB-Sant Pau), 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8639-2882","authenticated-orcid":false,"given":"Paolo","family":"Cameli","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, Surgery & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-1275","authenticated-orcid":false,"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, Surgery & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-3703","authenticated-orcid":false,"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences & Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in Churg-Strauss Syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1093\/rheumatology\/keaa805","article-title":"Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)","volume":"60","author":"Papo","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"ref_4","first-page":"221","article-title":"Epidemiology and Management of Interstitial Lung Disease in ANCA-Associated Vasculitis","volume":"38","author":"Sebastiani","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.55563\/clinexprheumatol\/3jl4uf","article-title":"Pleuroparenchymal Fibroelastosis in Interstitial Lung Disease with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"39","author":"Bargagli","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"210123","DOI":"10.1183\/16000617.0123-2021","article-title":"Antineutrophil Cytoplasmic Antibody-Associated Interstitial Lung Disease: A Review","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11926-013-0383-6","article-title":"Classification of ANCA-Associated Vasculitis","volume":"15","author":"Khan","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1378\/chest.96.1.68","article-title":"New Serum Indicator of Interstitial Pneumonitis Activity. Sialylated Carbohydrate Antigen KL-6","volume":"96","author":"Kohno","year":"1989","journal-title":"Chest"},{"key":"ref_9","first-page":"151","article-title":"Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis","volume":"46","author":"Kohno","year":"1999","journal-title":"J. Med. Invest."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","article-title":"Utility of KL-6\/MUC1 in the Clinical Management of Interstitial Lung Diseases","volume":"50","author":"Ishikawa","year":"2012","journal-title":"Respir. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13023-016-0430-2","article-title":"MUC1 Gene Polymorphisms Are Associated with Serum KL-6 Levels and Pulmonary Dysfunction in Pulmonary Alveolar Proteinosis","volume":"11","author":"Bonella","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_12","first-page":"228","article-title":"Biomarkers to Identify ILD and Predict Lung Function Decline in Scleroderma Lung Disease or Idiopathic Pulmonary Fibrosis","volume":"32","author":"Kennedy","year":"2015","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis. Off. J. WASOG"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","article-title":"Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis","volume":"158","author":"Yokoyama","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/eci.13543","article-title":"Prognostic Role of KL-6 in SSc-ILD Patients with Pleuroparenchymal Fibroelastosis","volume":"51","author":"Bellisai","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22574","DOI":"10.1038\/s41598-021-01992-y","article-title":"Role of MUC1 Rs4072037 Polymorphism and Serum KL-6 Levels in Patients with Antisynthetase Syndrome","volume":"11","author":"Genre","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/resp.13988","article-title":"Serum Markers of Pulmonary Epithelial Damage in Systemic Sclerosis-Associated Interstitial Lung Disease and Disease Progression","volume":"26","author":"Stock","year":"2020","journal-title":"Respirology"},{"key":"ref_17","first-page":"121439","article-title":"Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis","volume":"2012","author":"Hk","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13730-013-0074-1","article-title":"Monitoring with Serum SP-A, SP-D, and KL-6 in a Patient with Interstitial Pneumonia Complicated with ANCA-Associated Glomerulonephritis","volume":"3","author":"Takahashi","year":"2014","journal-title":"CEN Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2169\/internalmedicine.40.1093","article-title":"Serum Levels of KL-6 Reflect Disease Activity of Interstitial Pneumonia Associated with ANCA-Related Vasculitis","volume":"40","author":"Iwata","year":"2001","journal-title":"Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10157-009-0250-y","article-title":"Mizoribine Reduces Serum KL-6 Levels in ANCA-Associated Vasculitis","volume":"14","author":"Fujita","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA Recommendations for the Management of ANCA-Associated Vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Makhzoum, J.-P., Grayson, P.C., Ponte, C., Robson, J., Suppiah, R., Watts, R.A., Luqmani, R., Merkel, P.A., and Pagnoux, C. (2021). DCVAS collaborators Pulmonary Involvement in Primary Systemic Vasculitides. Rheumatology (Oxford), keab325.","DOI":"10.1093\/rheumatology\/keab325"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sebastiani, M., Luppi, F., Sambataro, G., Castillo Villegas, D., Cerri, S., Tomietto, P., Cassone, G., Bocchino, M., Atienza-Mateo, B., and Cameli, P. (2021). Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122548"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 Predicts Increased Risk for Acute Exacerbation of Idiopathic Pulmonary Fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/crj.12946","article-title":"The Serum KL-6 Levels in Untreated Idiopathic Pulmonary Fibrosis Can Naturally Decline in Association with Disease Progression","volume":"12","author":"Ishii","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro, M., Bergantini, L., Cameli, P., Pieroni, M., Refini, R.M., Sestini, P., and Bargagli, E. (2021). Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. Cancers, 13.","DOI":"10.1183\/13993003.congress-2021.PA385"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Huang, T.-H., Kuo, C.-W., Chen, C.-W., Tseng, Y.-L., Wu, C.-L., and Lin, S.-H. (2021). Baseline Plasma KL-6 Level Predicts Adverse Outcomes in Patients with Idiopathic Pulmonary Fibrosis Receiving Nintedanib: A Retrospective Real-World Cohort Study. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01530-6"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","article-title":"Prognostic Value of Circulating KL-6 in Idiopathic Pulmonary Fibrosis","volume":"11","author":"Yokoyama","year":"2006","journal-title":"Respirology (Carlton Vic.)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An Update on the Epidemiology of ANCA-Associated Vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/1\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:26:59Z","timestamp":1760362019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/1\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["biology11010094"],"URL":"https:\/\/doi.org\/10.3390\/biology11010094","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}